Myeloma escape from immunity: an “inside” job.
Rapoport AP. Blood. 2015 Sep 17;126(12):1401-3. doi: 10.1182/blood-2015-07-659490.

Antibody based immunotherapy for multiple myeloma: It’s about time.
Sher T et al, Leuk Lymphoma. 2015 Sep 16:1-17. [Epub ahead of print].

Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.
Karp Leaf R et al. Curr Hematol Malig Rep. 2015 Sep 4. [Epub ahead of print].

Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort.
Grelaud A et al. Leuk Lymphoma. 2015 Sep 23:1-17. [Epub ahead of print].

A case of melphalan sustained accumulation in an 80-year old patient.
Jolivot PA et al. Int J Clin Pharm. 2015 Sep 22. [Epub ahead of print].

Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies.
Dalia S et al. Leuk Res. 2015 Sep 9. pii: S0145-2126(15)30378-7. doi: 10.1016/j.leukres.2015.09.008. [Epub ahead of print].

Haematological cancer: A novel risk-classification tool for multiple myeloma.
[No authors listed]. Nat Rev Clin Oncol. 2015 Sep 22. doi: 10.1038/nrclinonc.2015.163. [Epub ahead of print].

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.
Ozaki S et al. Blood Cancer J. 2015 Sep 18;5:e349. doi: 10.1038/bcj.2015.79.

Targeting B-cell maturation antigen in multiple myeloma.
Tai YT et al. Immunotherapy. 2015 Sep 15. [Epub ahead of print].

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs.
Gooding S et al. PLoS One. 2015 Sep 14;10(9):e0136207. doi: 10.1371/journal.pone.0136207. eCollection 2015.

1,3-Butadiene, styrene and lymphohematopoietic cancer among male synthetic rubber industry workers – Preliminary exposure-response analyses.
Sathiakumar N et al. Chem Biol Interact. 2015 Sep 5. pii: S0009-2797(15)00284-7. doi: 10.1016/j.cbi.2015.09.003. [Epub ahead of print].

Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O et al. JAMA Oncol. 2015 Sep 3. doi: 10.1001/jamaoncol.2015.2938. [Epub ahead of print].

Clinical treatment of newly diagnosed multiple myeloma.
Cejalvo MJ et al. Expert Rev Hematol. 2015 Oct;8(5):595-611. doi: 10.1586/17474086.2015.1078236. Epub 2015 Sep 1.

Clinical and epidemiological features of multiple myeloma patients from a low socio-economic region of Brazil.
Minnicelli C et al. Rev Bras Hematol Hemoter. 2015 Sep-Oct;37(5):354-5. doi: 10.1016/j.bjhh.2015.05.007. Epub 2015 Jul 2